Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
PK Judge(Unknown), A. Q. Adeleke(Universiti Malaysia Pahang Al-Sultan Abdullah), SJ Hauske(Boehringer Ingelheim (Germany)), Karl Wallendszus, Julie Green, Natalie Staplin(University of Oxford), David Z.I. Cherney(University Health Network), Colin Baigent(University of Oxford), Jonathan Emberson(University of Oxford), Christoph Wanner(Universitätsklinikum Würzburg), Masaomi Nangaku(The University of Tokyo), David Preiss(Medical Research Council), Takashi Kadowaki(Toranomon Hospital), Adeera Levin(University of British Columbia), Katherine R. Tuttle(Providence Regional Medical Center Everett), Xavier Rosselló(Spanish National Centre for Cardiovascular Research), Dominik Steubl(Boehringer Ingelheim (Germany)), Nader G. Abraham(Duke University), Rajat Deo, WG Herrington(Boehringer Ingelheim (Germany)), Emily Sammons(University of Oxford), Rizna Abdul Cader(Boehringer Ingelheim (Germany)), MZ Abdul Wahab, AK Cheung, Talal Abdulsamad, Martin Landray(Gentofte Hospital), Roberto Pontremoli(Ospedale Policlinico San Martino), Daisy Massey, Susanne Brenner, Shinichi Goto, Aldo P. Maggioni(Health Care Foundation), Richard Haynes, Riaz Rahman, S Abat, P Achiri, J Li(Shandong University), Wenjun Liu(Liaoning University of Traditional Chinese Medicine), Zhihong Liu(Chinese Academy of Sciences), NK Abdullah, Dandan Zhu, MI Abdul Hafidz, AJ Roddick, LS Hooi, W. Grant Stevens, Sarah Acheampong, KJ Mayne, SYA Ng, Masanori Abe(Japanese Society for Dialysis Therapy), JA Acosta, Michael Hill(University of Ottawa)
Cited by 107
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
|Annals of Internal Medicine|2003|4.6k